- Home
- INBS vs ERNA Comparison
INBS vs ERNA Comparison
Compare INBS & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- ERNA
- Stock Information
- Founded
- INBS 2016
- ERNA 2018
- Country
- INBS United States
- ERNA United States
- Employees
- INBS N/A
- ERNA N/A
- Industry
- INBS Medical Specialities
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- ERNA Health Care
- Exchange
- INBS Nasdaq
- ERNA Nasdaq
- Market Cap
- INBS 11.7M
- ERNA 13.5M
- IPO Year
- INBS N/A
- ERNA N/A
- Fundamental
- Price
- INBS $1.47
- ERNA $1.59
- Analyst Decision
- INBS
- ERNA
- Analyst Count
- INBS 0
- ERNA 0
- Target Price
- INBS N/A
- ERNA N/A
- AVG Volume (30 Days)
- INBS 188.1K
- ERNA 83.3K
- Earning Date
- INBS 08-15-2025
- ERNA 08-13-2025
- Dividend Yield
- INBS N/A
- ERNA N/A
- EPS Growth
- INBS N/A
- ERNA N/A
- EPS
- INBS N/A
- ERNA N/A
- Revenue
- INBS $3,052,532.00
- ERNA $488,000.00
- Revenue This Year
- INBS $280.88
- ERNA N/A
- Revenue Next Year
- INBS $126.26
- ERNA N/A
- P/E Ratio
- INBS N/A
- ERNA N/A
- Revenue Growth
- INBS N/A
- ERNA 201.24
- 52 Week Low
- INBS $1.00
- ERNA $1.50
- 52 Week High
- INBS $3.00
- ERNA $28.80
- Technical
- Relative Strength Index (RSI)
- INBS 41.02
- ERNA 37.07
- Support Level
- INBS $1.42
- ERNA $1.62
- Resistance Level
- INBS $1.53
- ERNA $1.70
- Average True Range (ATR)
- INBS 0.09
- ERNA 0.10
- MACD
- INBS -0.01
- ERNA 0.01
- Stochastic Oscillator
- INBS 25.00
- ERNA 20.73
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.